Gabapentin Compounded Cream
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Gabapentin Compounded Cream contains NLT 90.0% and NMT 110.0% of the labeled amount of gabapentin (C9H17NO2).
Prepare Gabapentin Compounded Cream, 20 mg/g and 100 mg/g as follows (see Pharmaceutical Compounding—Nonsterile Preparations 〈795〉).
To Prepare a Gabapentin Compounded Cream containing 20 mg/g of gabapentin:
Gabapentin | 2 g |
Propylene Glycol | 5 mL |
Lipoderma, a sufficient quantity to make | 100 g |
a PCCA, Houston, TX.
To Prepare a Gabapentin Compounded Cream containing 100 mg/g of gabapentin:
Gabapentin | 10 g |
Propylene Glycol | 10 mL |
Lipoderma, a sufficient quantity to make | 100 g |
a PCCA, Houston, TX.
In an appropriately sized electronic mortar and pestle container, add 50 g of Lipoderm, then place the Gabapentin and Propylene Glycol on top, then add sufficient Lipoderm to bring to final weight. Mix the mixture with an electronic mortar and pestle for 5 min on a speed of about 1500 rpm. Process through an ointment mill once at the middle setting and once at the nest setting to reduce the particle size of the active ingredient and reduce air content of the preparation. Return the mixture to the electronic mortar and pestle container and mix again for 3–5 min on a speed of about 1100 rpm.
2 ASSAY
Procedure
Solution A: A solution of 1.44 g/L of ammonium acetate in water, adjusted using glacial acetic acid to a pH of 4.0. Pass through a polyvinyl difluoride filter of 0.22-µm pore size.
Mobile phase: Solution A and acetonitrile (15:85)
Standard stock solution: 2 mg/mL of USP Gabapentin RS in methanol. Sonicate for 2 min and vortex.
Standard solutions: Prepare ve calibration standard solutions having the concentrations of gabapentin in Table 1, by diluting Standard stock solution with methanol.
Table 1
Assay Level | Final Concentration (mg/mL) |
80% | 0.32 |
90% | 0.36 |
100% | 0.40 |
110% | 0.44 |
120% | 0.48 |
Sample solution of 20 mg/g Gabapentin Cream: Collect about 2 mL of Cream into a 3-mL syringe, avoiding air gaps. Transfer the Cream from a 3-mL syringe into a 1-mL syringe until fully filled. Insert the piston and move to about 5 mm above the 1-mL mark. Wipe excess Cream off the outside of syringe. Weigh the full syringe and record the weight. Fill a 50-mL volumetric ask with 25 mL of methanol (wet the neck of the ask with methanol) and transfer the Cream into the ask. Weigh the empty syringe (the difference between the original and nal weight should be between 900 and 1100 mg). Vortex the ask for 3 min, sonicate for 5 min, and then vortex for 2 min. Bring the ask to volume with methanol. Vortex for 2 min (the solution should be partially cloudy). Pass through a 0.45-µm polyvinylidene fluoride (PVDF) filter, discard the first 3 mL, and then transfer into an HPLC vial.
Sample solution of 100 mg/g Gabapentin Cream: Collect about 2 mL of Cream into a 3-mL syringe, avoiding air gaps. Transfer the Cream from a 3-mL syringe into a 1-mL syringe until fully filled. Insert the piston and move to about 5 mm above the 1-mL mark. Wipe excess Cream off the outside of the syringe. Weigh the full syringe and record the weight. Fill a 250-mL volumetric ask with 25 mL of methanol (wet the neck of the ask with methanol) and transfer Cream into the ask. Weigh the empty syringe (the difference between the original and nal weight should be between 900 and 1100 mg). Vortex the ask for 3 min, sonicate for 5 min, and then vortex for 2 min. Bring ask to volume with methanol. Vortex for 2 min (the solution should be partially cloudy). Pass through a 0.45-µm PVDF filter, discard the first 3 mL, and then transfer into an HPLC vial.
2.1 Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: Evaporative light-scattering
Drift tube temperature: 50°
Gain: 8
Offset: 0 mV
Sampling rate: 100 ms
Filter: 5 s
Gas: 3.5 bar
Column: 4.6-mm × 15-cm; 3.5-µm packing L68
Temperatures
Autosampler: 10°
Column: 50°
Flow rate: 1.0 mL/min
Injection volume: 10 μL
2.2 System suitability
Sample: 100% calibration Standard solution (0.40 mg/mL)
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 3.5% for six standard injections
2.3 Analysis
Samples: Each of the Standard solutions and Sample solution in triplicate
Identify the gabapentin peaks in the chromatogram of the Sample solution by comparison with the chromatograms obtained from the Standard solutions. Measure the areas of the gabapentin peaks. Plot the logarithms of the average peak area versus the logarithms of the concentrations, in mg/mL, of gabapentin obtained from the Standard solutions and determine the linear regression line using a least-squares analysis. The correlation coefficient for the linear regression line is NLT 0.995. From the graphs so obtained, determine the concentration, C, in mg/mL, of the gabapentin in the Sample solution.
Calculate the percentage of the labeled amount of gabapentin (C9H17NO2) in the portion of Cream taken:
Result = (CV/W) × 100
C = concentration of Gabapentin in the Sample solution (mg/mL)
V = volume of Gabapentin in the Sample solution (mL)
W = weight of Cream in the Sample solution (mg)
Acceptance criteria: 90.0%–110.0%
3 SPECIFIC TESTS
pH 〈791〉
For 20 mg/g Cream: 5.8–6.8
For 100 mg/g Cream: 6.0–7.0
Appearance: Opaque, white cream
4 ADDITIONAL REQUIREMENTS
Packaging and Storage: Package in a metered-dose, plastic container. Store at controlled room temperature.
Beyond-Use Date: NMT 90 days from the date on which it was compounded when stored at controlled room temperature. Preparations have passed Antimicrobial Effectiveness Testing 〈51〉.
Labeling: Label it for external use only and to state the Beyond-Use Date.
USP Reference Standards 〈11〉
USP Gabapentin RS (USP 1-Dec-2023)

